{"product_id":"hcahealthcare-pestle-analysis","title":"HCA Healthcare PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eAssess how regulatory shifts, reimbursement pressures, and technological innovation are reshaping HCA Healthcare’s competitive landscape—our PESTLE Analysis distills these external forces into actionable insights to inform investment and strategic decisions. Purchase the full report for a complete, ready-to-use breakdown that saves research time and empowers smarter planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePost-Election Healthcare Policy Shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe 2024 U.S. presidential election drove policy shifts into 2025 that put the Affordable Care Act's subsidy structure and Medicaid expansion under review, with CMS projections estimating up to 4–6% swings in insured population for states altering expansion status; HCA Healthcare faces revenue sensitivity as roughly 40% of its patient mix is publicly insured. Analysts track executive orders and congressional agendas that could change Medicare\/Medicaid reimbursement rates—Medicare margins for hospitals averaged 1.5% in 2024—potentially impacting HCA's 2025 operating income. HCA must model scenarios for reduced federal subsidies and program restructuring that could shift uninsured rates and uncompensated care costs, which were $1.2 billion industry-wide in 2023–2024 estimates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare Reimbursement Rate Adjustments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFederal budget talks in late 2025 pressured Medicare Advantage and traditional Medicare rates; CMS projected 2026 base rate growth near 1.5% vs. 2025 inflation ~3.4%, risking margin compression for HCA, whose 2024 Medicare revenue represented roughly 30% of patient mix. Reduced real reimbursement would cut operating margins (HCA 2024 adjusted EBITDA margin 13.8%). HCA is intensifying lobbying for payment models reflecting rising specialist and ER costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eState-Level Certificate of Need Regulations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eState-level Certificate of Need regulations in Florida and Texas materially affect HCA Healthcare’s expansion—Florida’s CON framework and Texas’s partial deregulation shape approval timelines for new facilities in markets where HCA reported $58.7B revenue in 2024. Changes to CON laws can shield HCA’s existing market share or open corridors to competitors, impacting projected capital expenditures (HCA capex was $2.9B in 2024). HCA’s strategic planning prioritizes navigating local political climates to secure approvals for freestanding ERs and hospital wings, which drive regional growth and margin expansion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Oversight of Consolidation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eFederal scrutiny of healthcare consolidation intensified in 2024–2025, with DOJ and FTC actions rising 22% year-over-year; HCA’s deals for regional hospitals and physician groups face rigorous antitrust review to avoid creating local monopolies.\u003c\/p\u003e\n\u003cp\u003ePolitical pressure to cut costs drives transparency mandates—CMS and state laws expanded reporting, affecting HCA’s $64.4B 2024 revenue and M\u0026amp;A disclosures.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDOJ\/FTC enforcement +22% YoY (2024–25)\u003c\/li\u003e\n\u003cli\u003eHCA 2024 revenue $64.4B—subject to increased disclosure\u003c\/li\u003e\n\u003cli\u003eM\u0026amp;A deals face stricter local monopoly scrutiny\u003c\/li\u003e\n\u003cli\u003eExpanded CMS\/state reporting requirements raise compliance costs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Health Funding and Preparedness\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eFederal and state allocations for public health infrastructure—US CDC funding rose to about $9.5 billion in FY2025 for preparedness—directly affect HCA Healthcare’s readiness for large-scale crises by determining capacity-building grants and surge funding.\u003c\/p\u003e\n\u003cp\u003ePolitical choices on nursing education and GME funding—federal Title VIII and Medicare GME totals near $16B–$18B annually—shape the long-term talent pipeline HCA relies on.\u003c\/p\u003e\n\u003cp\u003eAligning capital investments with national health security priorities lets HCA access FEMA\/CDC grants and public-private partnerships, enhancing ROI on emergency facilities and tech upgrades.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCDC preparedness funding ~ $9.5B (FY2025)\u003c\/li\u003e\n\u003cli\u003eMedicare GME + Title VIII funding ~$16B–$18B\/year\u003c\/li\u003e\n\u003cli\u003eCapital alignment increases eligibility for FEMA\/CDC grants\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHCA at Risk: Policy, Medicaid Uncertainty \u0026amp; Rising DOJ\/FTC Scrutiny Threaten Margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical shifts in 2024–25—ACA subsidy reviews, Medicaid expansion uncertainty, and tighter DOJ\/FTC M\u0026amp;A enforcement (+22% YoY)—threaten HCA’s public-pay revenue (≈40% patient mix; 2024 revenue $64.4B) and could compress margins (2024 adj. EBITDA margin 13.8%) via lower Medicare\/Medicaid rates and higher compliance costs.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 revenue\u003c\/td\u003e\n\u003ctd\u003e$64.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic-pay mix\u003c\/td\u003e\n\u003ctd\u003e≈40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdj. EBITDA margin 2024\u003c\/td\u003e\n\u003ctd\u003e13.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDOJ\/FTC enforcement Δ\u003c\/td\u003e\n\u003ctd\u003e+22% YoY (2024–25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how macro-environmental factors specifically impact HCA Healthcare across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with data-backed trends, region-specific regulatory context, and forward-looking insights to inform strategy, risk mitigation, and investor communications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, visually segmented PESTLE summary for HCA Healthcare that clarifies regulatory, economic, and technological pressures—ready to drop into presentations, annotate with regional notes, and share across teams to streamline risk discussions and strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor Cost Inflation and Nursing Shortages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite headline CPI easing to about 3.4% by Dec 2025, healthcare labor inflation remains elevated with RN wage growth near 6–8% in 2024–25; HCA reported contract labor expense of $2.1 billion in FY2024 and is expanding its internal staffing arm to cut agency spend. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Environment and Capital Expenditure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAt end-2025, a US Fed funds rate around 5.25–5.50% raised HCA Healthcare’s effective borrowing costs, prompting more selective capital allocation for its $8.5bn+ long-term debt; higher rates increase annual interest expense and weigh on returns from new facility projects. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumer Healthcare Spending Patterns\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEconomic fluctuations affect elective and outpatient demand—high-margin segments for HCA—evidenced by a 2023 U.S. decline in elective procedures during the 2023 rate hikes and a partial recovery in 2024; with HDHP enrollment at about 34% of workers in 2024, patient price-sensitivity shifts volume toward outpatient settings, and HCA tracks unemployment (3.7% Jan 2025) and real disposable income trends to forecast non-emergency service demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain Pricing and Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGlobal supply-chain disruptions raised hospital supply costs by about 6–9% in 2023–2024; HCA’s $60+ billion purchasing scale lets it secure discounts and reduced COGS, yet geopolitical events (e.g., 2022–24 semiconductor and China export tensions) risk delays in high-tech imaging and pharma inputs.\u003c\/p\u003e\n\u003cp\u003eHCA’s focus on strategic inventory, just-in-case buffers and diversified suppliers helps protect margins amid volatile freight rates and a 2024 global air cargo rate rebound of ~15% year-over-year.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eScale: $60+ billion procurement leverage\u003c\/li\u003e\n\u003cli\u003eCost impact: 6–9% supply cost increase (2023–24)\u003c\/li\u003e\n\u003cli\u003eRisk: geopolitical shocks to manufacturing and semiconductors\u003c\/li\u003e\n\u003cli\u003eMitigation: inventory buffers, diversified sourcing, strategic contracts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayer Mix and Managed Care Dynamics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe economic health of commercial insurers and the negotiation of managed care contracts are critical to HCA's revenue stability; in 2024 commercial payers accounted for roughly 52% of HCA's consolidated revenue, while government programs (Medicare\/Medicaid) made up about 44%.\u003c\/p\u003e\n\u003cp\u003eShifts toward government-funded programs typically lower average reimbursement per patient—Medicare payments are often 10–20% below private rates, and Medicaid can be 30–40% lower depending on state.\u003c\/p\u003e\n\u003cp\u003eHCA's ability to secure favorable terms with major private insurers, such as recent contract renewals with large national payers covering millions of lives, directly affects margin performance in competitive markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 payer split: ~52% commercial, ~44% government\u003c\/li\u003e\n\u003cli\u003eMedicare ≈10–20% below private rates; Medicaid ≈30–40% below\u003c\/li\u003e\n\u003cli\u003eFavorable insurer contracts drive margins and volume access\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHCA margins squeezed by rising RN pay, $2.1B contract labor, higher rates and supply costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eElevated labor inflation (RN wages +6–8% in 2024–25) and $2.1bn FY2024 contract labor drove margin pressure while HCA scales internal staffing; Fed funds ~5.25–5.50% end‑2025 raised interest costs on $8.5bn+ debt, tightening capex; elective\/outpatient demand recovered in 2024 amid 34% HDHP enrollment, and supply costs rose ~6–9% (2023–24) with procurement scale ($60+bn) mitigating risk.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eContract labor FY2024\u003c\/td\u003e\n\u003ctd\u003e$2.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRN wage growth 2024–25\u003c\/td\u003e\n\u003ctd\u003e6–8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed funds (end‑2025)\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLong‑term debt\u003c\/td\u003e\n\u003ctd\u003e$8.5bn+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement scale\u003c\/td\u003e\n\u003ctd\u003e$60+bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupply cost rise (2023–24)\u003c\/td\u003e\n\u003ctd\u003e6–9%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHDHP enrollment (2024)\u003c\/td\u003e\n\u003ctd\u003e~34%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eHCA Healthcare PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact HCA Healthcare PESTLE document you’ll receive after purchase—fully formatted, professionally structured, and ready to use for strategy or investment analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751282356601,"sku":"hcahealthcare-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/hcahealthcare-pestle-analysis.png?v=1772229729","url":"https:\/\/growthsharematrix.com\/products\/hcahealthcare-pestle-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}